Advanced hepatocellular carcinoma responds to MK615, a compound extract from the Japanese apricot &ldquo;Prunus mume&rdquo;

doi:10.4254/wjh.v5.i10.596

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 10

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4515)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

335

HTML

2538

Figures (1-2)

122

Tables (1-1)

106

Sum=3101

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

940

Download

474

Sum=1414

Oct 27, 2013 (publication date) through Apr 30, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Hepatol. Oct 27, 2013; 5(10): 596-600
Published online Oct 27, 2013. doi: 10.4254/wjh.v5.i10.596

Table 1 Characteristics of the patients who received MK615 for more than 3 mo

Case	Sex	Age	Stage	CP	Previous treatment	Duration (mo)	Response	Cause of death
1	F	64	IVA	A	5FU + IFN, Sorafenib	3	PD	HCC progression
2	F	85	IVA	C	None	3	SD	HCC progression
3	M	63	IVA	C	None	6.5	SD-PD	HCC progression
4	M	57	IVA	A	TACE	3	PD	HCC progression
5	F	73	IVA	C	None	6	PD	Survived
This case	F	60	IVB	A	Surgery, RFA, TAI	17	PR	Survived

CP: Child-Pugh classification, duration; duration of MK615 treatment; F/M: Female/male; HCC: Hepatocellular carcinoma; RFA: Radiofrequency ablation; TACE: Transarterial chemoembolization; TAI: Transcatheter arterial infusion chemotherapy.

Citation: Hoshino T, Takagi H, Naganuma A, Koitabashi E, Uehara S, Sakamoto N, Kudo T, Sato K, Kakizaki S. Advanced hepatocellular carcinoma responds to MK615, a compound extract from the Japanese apricot “Prunus mume”. World J Hepatol 2013; 5(10): 596-600
URL: https://www.wjgnet.com/1948-5182/full/v5/i10/596.htm
DOI: https://dx.doi.org/10.4254/wjh.v5.i10.596